NO143944C - Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridinsubstituerte pyrrolidinderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridinsubstituerte pyrrolidinderivater

Info

Publication number
NO143944C
NO143944C NO760561A NO760561A NO143944C NO 143944 C NO143944 C NO 143944C NO 760561 A NO760561 A NO 760561A NO 760561 A NO760561 A NO 760561A NO 143944 C NO143944 C NO 143944C
Authority
NO
Norway
Prior art keywords
ingrediates
preparation
therapeutically active
analogy procedure
active pyridine
Prior art date
Application number
NO760561A
Other languages
English (en)
Norwegian (no)
Other versions
NO760561L (xx
NO143944B (no
Inventor
Karl Bernauer
Karlheinz Pfoertner
Fernand Schneider
Hans Schmid
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH223175A external-priority patent/CH619461A5/de
Priority claimed from CH1640575A external-priority patent/CH619706A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO760561L publication Critical patent/NO760561L/no
Publication of NO143944B publication Critical patent/NO143944B/no
Publication of NO143944C publication Critical patent/NO143944C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO760561A 1975-02-21 1976-02-20 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridinsubstituerte pyrrolidinderivater NO143944C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH223175A CH619461A5 (en) 1975-02-21 1975-02-21 Process for the preparation of heterocyclic compounds
CH1640575A CH619706A5 (en) 1975-12-18 1975-12-18 Process for the preparation of heterocyclic compounds

Publications (3)

Publication Number Publication Date
NO760561L NO760561L (xx) 1976-08-24
NO143944B NO143944B (no) 1981-02-02
NO143944C true NO143944C (no) 1981-05-13

Family

ID=25689857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO760561A NO143944C (no) 1975-02-21 1976-02-20 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyridinsubstituerte pyrrolidinderivater

Country Status (27)

Country Link
US (1) US3991197A (xx)
JP (1) JPS51108074A (xx)
AT (1) AT347948B (xx)
AU (1) AU500184B2 (xx)
BR (1) BR7601094A (xx)
CA (1) CA1064931A (xx)
DD (1) DD124385A5 (xx)
DE (1) DE2606530A1 (xx)
DK (1) DK138948B (xx)
DO (1) DOP1976002535A (xx)
ES (1) ES445339A1 (xx)
FI (1) FI62298C (xx)
FR (1) FR2301252A1 (xx)
GB (2) GB1527524A (xx)
GR (1) GR59272B (xx)
HU (1) HU174452B (xx)
IE (1) IE42638B1 (xx)
IL (1) IL48904A (xx)
LU (1) LU74381A1 (xx)
NL (1) NL7601760A (xx)
NO (1) NO143944C (xx)
NZ (1) NZ179859A (xx)
PH (1) PH13135A (xx)
PL (1) PL101913B1 (xx)
PT (1) PT64832B (xx)
SE (1) SE421694B (xx)
YU (1) YU35476A (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015741A (en) * 1989-10-03 1991-05-14 Philip Morris Incorporated Nicotine analogs

Also Published As

Publication number Publication date
FR2301252A1 (fr) 1976-09-17
ATA123276A (de) 1978-06-15
DOP1976002535A (es) 1982-10-23
AU500184B2 (en) 1979-05-10
US3991197A (en) 1976-11-09
DE2606530A1 (de) 1976-09-02
NZ179859A (en) 1978-07-10
SE421694B (sv) 1982-01-25
IL48904A0 (en) 1976-03-31
IL48904A (en) 1979-03-12
PT64832A (fr) 1976-03-01
BR7601094A (pt) 1976-09-14
AT347948B (de) 1979-01-25
AU1062976A (en) 1977-08-04
DK72876A (xx) 1976-08-22
PT64832B (fr) 1979-01-16
NO760561L (xx) 1976-08-24
LU74381A1 (xx) 1977-09-12
NL7601760A (nl) 1976-08-24
ES445339A1 (es) 1977-06-01
DD124385A5 (xx) 1977-02-16
GR59272B (en) 1977-12-05
GB1527525A (en) 1978-10-04
FI62298C (fi) 1982-12-10
PL101913B1 (pl) 1979-02-28
GB1527524A (en) 1978-10-04
FI62298B (fi) 1982-08-31
PH13135A (en) 1979-12-12
FR2301252B1 (xx) 1979-09-21
SE7602069L (sv) 1976-08-23
NO143944B (no) 1981-02-02
IE42638L (en) 1976-08-21
FI760420A (xx) 1976-08-22
HU174452B (hu) 1980-01-28
DK138948C (xx) 1979-05-07
IE42638B1 (en) 1980-09-24
CA1064931A (en) 1979-10-23
DK138948B (da) 1978-11-20
JPS51108074A (xx) 1976-09-25
YU35476A (en) 1982-10-31

Similar Documents

Publication Publication Date Title
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO146909C (no) Fremgangsmaate til fremstilling av terapeutisk virksomme pyrrolidinderivater.
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO147109C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO149311C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive propanolindolderivater
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO147150C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner.
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO144604C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme histidinderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO145620C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere.
NO142907C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme fenylalkylaminer